Regulatory aspects of digital transformation in the biotechnology sector

Aim. Analysis of the effectiveness of monetary policy controlling inflation under conditions of simultaneous demand and supply shocks.

Methodology. The most conventional linear representations of New Keynesian models (AD-AS and IS-LM-PC), bibliographic and qualitative methods of analysis are used.

Results. Under conditions of simultaneous demand and supply shocks, an effective monetary policy aimed at controlling inflation is achieved by a one-time, timely increase in the key rate, as well as by establishing an achievable inflation target, macro and micro prudential restrictions, tightening mandatory liquidity and capital ratios, and increasing the mandatory reserve ratio. At the same time, the key rate raise should have an upper limit and not lead to the accumulation of credit risk in the system.

Research implications. The study provides a theoretical foundation for regulatory recommendations in the field of digital transformation in biotechnology. The practical significance lies in creating conditions for the safe and ethical implementation of digital technologies, as well as in increasing public trust in new biotechnological solutions.

1. Tikhomirov, Y. A., Kichigin, N. V., Tsomartova, F. V. & Balkhaeva, S. B. (2021). Law and Digital Transformation Pravo. In: Law. Journal of the Higher School of Economics, 2, 4–23 (in Russ.).

2. Kazakevich, E. I. (2022). Human Rights and Freedoms Protection in the Processing of Personal Data in the Period of Digital Transformation. In: Ural Journal of Legal Research, 4, 36–46 (in Russ.).

3. Stepanova, M. N. (2025). Regulation of Legal Relations in the Era of Digital Transformation. In: Legal and Order: History, Theory, Practic, 1, 44–49 (in Russ.).

4. Han, Y., Fan, L. L & Xue, Y. (2024). A Sustainable Balance Between Innovation and Risk: How the “Right to Science” Affects China's Medical Biotechnology Regulatory Policy. In: Computer Structure Biotechnology Journal, 16, 24, 306–313. DOI: 10.1016/j.csbj.2024.04.027

5. Axelrad, H., Sumkin, S. & Haver, S. Promoting and Developing Digital Transformation in Israel toward 2030. In: The Aaron Institute’s Policy Papers. Policy Paper 2022.03 / April 2022. URL: https://www.researchgate.net/publication/360833080_Promoting_and_Developing_Digital_Transformation_in_Israel_toward_2030 (accessed: 07.11.2025).

6. Voeikova, T. A., Zhuravleva, O. A. & Debabov, V. G. (2020). Comparative Analysis of Legal Regulation of Industrial Use of Genetic-Engineering-Modified Microoranisms in the United States, the European Union and Russian Federation. In: Molecular Genetics, Microbiology and Virology, 38, 2, 67–75. DOI: 10.17116/molgen20203802167 (in Russ.).

7. Lapaeva, V. V. (2019). International Regulation of Relations of Biomedicine: Interaction of Law and Morality. In: Law. Journal of the Higher School of Economics, 2, 22–44 (in Russ.).

8. Shtansky, A. D. & Zheltenkov, A. V. (2025). Digital Transformation of Biotechnology Sector Organizations as a Factor of Innovative Development. In: Bulletin of the State University of Education. Series: Economics, 2, 122–131. DOI: 10.18384/2949-5024-2025-2-122-131 (in Russ.).

9. Semtsiva, S. I. (2023). Prospects of International Legal Regulation of the Use of Modern Biotechnologies. In: Legal Issues, 1, 21–26 (in Russ.).

10. Ilyushenko, N. S. (2020). Realities and Prospects of Knowledge Humanization in the Context of Biotechnological Development. In: Ideas and Ideals, 12, 3, 1, 164–175 (in Russ.).

11. Belyaletdinov, R. R. (2019). The Risks of Modern Biotechnologies: A Socio-Humanitarian Analysis. Moscow: 4 Print publ. (in Russ.).